Ann Flynn
( out of 91 reviews )

Ann Flynn, MD

Languages spoken: English

Clinical Locations

Primary Location

Gastroenterology /GI Clinic UUH

Gastroenterology, Area E
50 N Medical Dr
Salt Lake City , UT 84132
801-213-9797
Get Directions

Sugar House Health Center

Gastroenterology
1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-213-9797
Get Directions

Huntsman Cancer Institute - Cancer Hospital North

1K, Endoscopy
1950 Circle of Hope
Salt Lake City , UT 84112
801-213-9797
Get Directions

  • Dr. Flynn attended medical school at New York Medical College. She completed internal medicine residency training at the University of Colorado School of Medicine and gastroenterology fellowship training at the Indiana University School of Medicine. She completed an advanced fellowship in inflammatory bowel disease at Indiana University. Her clinical interests include diagnosis and management of inflammatory diseases of the GI tract including Crohn's disease, ulcerative colitis, and microscopic colitis. She is passionate about women's GI health, shared decision-making discussions, patient education, personalized care for patients with inflammatory bowel disease, and assisting patients transitioning care from pediatric to adult GI clinics. Dr. Flynn is a member of the American College of Gastroenterology Patient Care Committee and the Crohn's and Colitis Foundation Patient Education Committee. She currently serves as the American College of Gastroenterology Governor for Utah.

    The University of Utah Inflammatory Bowel Disease Program is a participating site in IBD Qorus, a collaboration between patients and healthcare providers to improve the quality of IBD care across the country, to ensure all patients receive the highest quality IBD care, treatment, and disease outcomes. Dr. Flynn serves as the IBD Qorus physician leader for the University of Utah.

    Dr. Flynn is board certified in Gastroenterology. She is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Gastroenterology)

    Patient Rating

    5.0 /5
    ( out of 91 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    UH HOSPITALS AND CLINICS

    Great! Shes fantastic and wonderful! I love her!!!

    UH HOSPITALS AND CLINICS

    Dr. Flynn was outstanding...she made me feel like she really cared about finding a good result for me. It was nice to finally feel like I was being heard

    UH HOSPITALS AND CLINICS

    I love Dr. Flynn. As a medically complicated patient, it's easy for doctors to have tunnel vision and ignore everything except the condition they specialize in and then suggest treatment options that just don't make sense with my other conditions. That's not Dr. Flynn. She is always very good at seeing me as a whole and tailoring IBD treatments suggestions to my own needs. She's a great listener and it's very obvious that she understands the lived experiences of people with IBD. Plus, she's just fun. I really can't say enough good things.

    UNIVERSITY HOSPITAL

    Dr Flynn is one of the best doctors that I have had the pleasure of knowing. She knows her field very well. She is kind and understanding. She has kept up with any problems that I have had. I would highly recommend her.

    UH HOSPITALS AND CLINICS

    This was my first visit with Dr. Flynn, and I was very impressed!

    UH HOSPITALS AND CLINICS

    i very much appreciste Dr. Flynn's knowledge and demeanor.

    UNIVERSITY HOSPITAL

    I love Dr. Flynn! She's takes such great care of me and always listens carefully and answers all my questions.

    UNIVERSITY HOSPITAL

    Dr. Flynn is very kind, caring and professional. She is a good listener and always includes you in your care. She explains things so you can understand. She is very helpful and cares about you as a person. She is the best!

    UNIVERSITY HOSPITAL

    She's an amazing doctor I fully trust her

  • Dr. Flynn attended medical school at New York Medical College. She completed internal medicine residency training at the University of Colorado School of Medicine and gastroenterology fellowship training at the Indiana University School of Medicine. She completed an advanced fellowship in inflammatory bowel disease at Indiana University. Her clinical interests include diagnosis and management of inflammatory diseases of the GI tract including Crohn's disease, ulcerative colitis, and microscopic colitis. She is passionate about women's GI health, shared decision-making discussions, patient education, personalized care for patients with inflammatory bowel disease, and assisting patients transitioning care from pediatric to adult GI clinics. Dr. Flynn is a member of the American College of Gastroenterology Patient Care Committee and the Crohn's and Colitis Foundation Patient Education Committee. She currently serves as the American College of Gastroenterology Governor for Utah.

    The University of Utah Inflammatory Bowel Disease Program is a participating site in IBD Qorus, a collaboration between patients and healthcare providers to improve the quality of IBD care across the country, to ensure all patients receive the highest quality IBD care, treatment, and disease outcomes. Dr. Flynn serves as the IBD Qorus physician leader for the University of Utah.

    Dr. Flynn is board certified in Gastroenterology. She is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Gastroenterology
    Board Certification
    American Board of Internal Medicine (Sub: Gastroenterology)

    Education history

    Undergraduate Molecular Biology, Senior Thesis: Identification of Genes Involved in Fab-7 boundary function by F2 EMS Mutagenesis Screen. - Princeton University A.B.
    Professional Medical Alpha Omega Alpha - New York Medical College M.D.
    Internship Internal Medicine - University of Colorado at Denver Intern
    Residency Internal Medicine - University of Colorado at Denver Resident
    Fellowship Gastroenterology and Hepatology - Indiana University Fellow
    Fellowship Gastroenterology and Hepatology - Indiana University Chief Fellow
    Fellowship Inflammatory Bowel Disease - Indiana University Advanced Fellow

    Selected Publications

    Journal Article

    1. Lewis JD, Sandler R, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF, Hanson J, Suskind D, Meyer A, Compher CW, Bewtra M, Saxena A, Dobes A, Cohen B, Flynn AD, Fischer M, Saha S, Swaminath A, Yacyshyn B, Scherl E, Horst S, Curtis JR, Braly K, Nessel L, McCauley M, McKeever L, Herfarth H, DINE-CD Study Group (2021). A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults with Crohn's Disease. Gastroenterology, 161, 837-852.e9. (Read full publication)
    2. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg T (2008). Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. Journal of general internal medicine, 23(2), 169-74. (Read full publication)
    3. Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer (2019). Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. American journal of transplantation, 19(2), 501-511. (Read full publication)
    4. Pozdnyakova V, Botwin GJ, Sobhani K, Prostko J, Braun J, Mcgovern DPB, Melmed GY, Appel K, Banty A, Feldman E, Ha C, Kumar R, Lee S, Rabizadeh S, Stein T, Syal G, Targan S, Vasiliauskas E, Ziring D, Debbas P, Hampton M, Mengesha E, Stewart JL, Frias EC, Cheng S, Ebinger J, Figueiredo JC, Boland B, Charabaty A, Chiorean M, Cohen E, Flynn A, Valentine J, Fudman D, Horizon A, Hou J, Hwang C, Lazarev M, Lum D, Fausel R, Reddy S, Mattar M, Metwally M, Ostrov A, Parekh N, Raffals L, Sheibani S, Siegel C, Wolf D, Younes (2021). Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease. Gastroenterology, 161(6), 2041-2043.e1. (Read full publication)
    5. Almario CV, Kogan L, van Deen WK, Scott FI, Singh S, Hou JK, Lum D, Aguilar H, Betteridge J, Flynn A, Gerich M, Kaufman L, Mattar MC, Mize C, Ostrov A, Shah SA, Younes Z, Weaver SA, Heller C, Siegel CA, Melmed G (2021). Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease. The American journal of gastroenterology, 116(12), 2459-2464. (Read full publication)
    6. Levic DS, Niedzwiecki D, Kandakatla A, Karlovich NS, Juneja A, Park J, Stolarchuk C, Adams S, Willer JR, Schaner MR, Lian G, Beasley C, Marjoram L, Flynn AD, Valentine JF, Onken JE, Sheikh SZ, Davis EE, Evason KJ, Garman KS, Bagnat M (2024). TNF promoter hypomethylation is associated with mucosal inflammation in IBD and anti-TNF response. medRxiv (preprint) 2024 Feb 6:2024. medRxiv,
    7. Singh S, Nguyen JD, Fudman DI, Gerich ME, Shah SA, Hudesman D, McConnell RA, Lukin DJ, Flynn AD, Hwang C, Sprung B, Gaidos JKJ, Mattar MC, Rubin DT, Hashash JG, Metwally M, Ali T, Ma C, Hoentjen F, Narula N, Bessissow T, Rosenfeld G, McCurdy JD, Ananthakrishnan AN, Cross RK, Rodriguez Gaytan JR, Gurrola ES, Patel S, Siegel CA, Melmed GY, Weaver SA, Power S, Zou G, Jairath V, Hou J (2025). Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial. BMJ open gastroenterology, 12(1), (Read full publication)

    Review

    1. Gawron LM, Sanders J, Steele K, Flynn (2016). Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases. Inflammatory bowel diseases, 22(2), 459-64.

    Abstract

    1. Youngblood BA, Butuci M, Davis T, Xu A, Schanin J, Brock EC, Singh B, Rasmussen HS, Holman A, Drake R, Peterson K, Flynn AD (2020). Phenotypic Characterization of Inflammatory Bowel Disease Biopsies Reveal That Mast Cells Are Significantly Elevated and Activated In Patients with Ulcerative Colitis . 26(Supplement 1), S33-34.
    2. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). Quality of Care Initiative Improves Outcomes for Patients with Inflammatory Bowel Disease. . 158(6), S-8-S-9.
    3. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). The IBD Urgent Care Toolkit: Which Process Changes are Associated with Successful Improvement?. 158(6), S-411.
    4. Melmed G, Hou JK, Lum D, Gerner D, Singh S, Crate DJ, Holthoff M, Kennedy AM, Aguilar H, Almario CV, Banty A, J Betteridge, Bhatti F, Bray H, Charabaty A, Dudley-Brown S, Fasanya-Uptagraft H, Fausel R, Fennimore B, Flynn AD, Gerich ME, Ghafari A, Ha C, Heagy E, Hudesman D, Hwang C, Kaufman L, Kaur N, Kim B, Mattar M, McCutcheon Adams K, Mehta F, Metwally M, Oliver BO, Ostrov A, Reddy S, Rubin DT, Scott FI, Shah S, Syal G, Valentine JF, van Deen WK, Vrabie R, Wang A, Williams E, Younes ZH, Yun L, Zisman T, Farraye FA, Nelson E, Heller C, Oberai R, Weaver A, Siegel CA (2020). Improvement in Inflammatory Bowel Disease Care Does Not Differ by Practice Type. 158(6), S-412.

    Video/Film/CD/Web/Podcast

    1. Ausk K, Flynn A, Fennimore (2016). Thinking about Colorectal Cancer. Understanding the Risks and Prevention.
    2. Diet and Nutrition Initiative, Flynn A, Eichelberger K, Issokson K, Shah R, Yen (2018). "IBD: Diet and Nutrition." Materials developed include webinar, animated videos, webpages, website, educational graphics, and an e-tool/game to provide patient education regarding malnutrition, food choices, nutritional support therapy, vitamin supplementation, and current research concerning diet and inflammatory bowel disease. Animated video topics include, "Malnutrition and IBD," "What to Eat when in a Flare," "What to Eat when in Remission," "Nutrition Support Therapy," and "Vitamin and Mineral Supplementation." A webinar on Complementary and Alternative Medicine for IBD is currently in development.